Alternate-day fasting reverses the age-associated hypertrophy phenotype in rat heart by influencing the ERK and PI3K signaling pathways
暂无分享,去创建一个
G. Poli | G. Testa | E. Chiarpotto | F. Biasi | G. Leonarduzzi | E. Bergamini | G. Cavallini | A. Donati | M. Maina | L. Castello | Marco Maina
[1] Douglas P. Zipes,et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition , 2011 .
[2] S. Rohrbach,et al. Caloric restriction delays cardiac ageing in rats: role of mitochondria. , 2010, Cardiovascular research.
[3] V. Dolinsky,et al. Calorie Restriction Prevents Hypertension and Cardiac Hypertrophy in the Spontaneously Hypertensive Rat , 2010, Hypertension.
[4] J. Hawley,et al. Aerobic training reverses high-fat diet-induced pro-inflammatory signalling in rat skeletal muscle , 2010, European Journal of Applied Physiology.
[5] M. Mattson,et al. “Control” laboratory rodents are metabolically morbid: Why it matters , 2010, Proceedings of the National Academy of Sciences.
[6] K. E. Jones,et al. Nutrient Stress Activates Inflammation and Reduces Glucose Metabolism by Suppressing AMP-Activated Protein Kinase in the Heart , 2009, Diabetes.
[7] Sterling C. Johnson,et al. Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys , 2009, Science.
[8] K. Okumura,et al. Mechanism of Diastolic Stiffening of the Failing Myocardium and Its Prevention by Angiotensin Receptor and Calcium Channel Blockers , 2009, Journal of cardiovascular pharmacology.
[9] S. Clément,et al. Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation. , 2009, American journal of physiology. Heart and circulatory physiology.
[10] Richard Weindruch,et al. Caloric Restriction and Aging: Studies in Mice and Monkeys , 2009, Toxicologic pathology.
[11] A. D. de Bold,et al. Cardiac Natriuretic Peptides Gene Expression and Secretion in Inflammation , 2009, Journal of Investigative Medicine.
[12] H. Drexler,et al. The myocardial JAK/STAT pathway: from protection to failure. , 2008, Pharmacology & therapeutics.
[13] D. Hilfiker-Kleiner,et al. Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspects , 2008, British journal of pharmacology.
[14] E. Frohlich,et al. The aging hypertensive heart: a brief update , 2008, Nature Clinical Practice Cardiovascular Medicine.
[15] J. Holloszy,et al. Caloric restriction in humans , 2007, Experimental Gerontology.
[16] D. Kass,et al. Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface , 2007, Nature Reviews Drug Discovery.
[17] G. Dorn. The Fuzzy Logic of Physiological Cardiac Hypertrophy , 2007, Hypertension.
[18] G. Norton,et al. Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function. , 2007, Pharmacological research.
[19] P. Kopelman. Health risks associated with overweight and obesity , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[20] Corby K. Martin,et al. Effect of calorie restriction with or without exercise on body composition and fat distribution. , 2007, The Journal of clinical endocrinology and metabolism.
[21] J. Molkentin,et al. Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.
[22] R. Kennedy,et al. Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes. , 2006, Journal of molecular and cellular cardiology.
[23] F. Ohsuzu,et al. Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1. , 2006, American journal of physiology. Heart and circulatory physiology.
[24] S. Clément,et al. Correlation of α‐skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats , 2006 .
[25] J. Dhahbi,et al. Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[26] A. Gradman,et al. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. , 2006, Progress in cardiovascular diseases.
[27] A. Clerk,et al. Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes. , 2006, Cellular signalling.
[28] A. Sapino,et al. Calorie restriction protects against age‐related rat aorta sclerosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] J. Lecron,et al. Role of interleukin‐6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation , 2005, Journal of cellular physiology.
[30] E. Abel,et al. Akt1 in the cardiovascular system: friend or foe? , 2005, The Journal of clinical investigation.
[31] Bruce Jones,et al. The diet restriction paradigm: a brief review of the effects of every-other-day feeding , 2005, AGE.
[32] S. Kong,et al. Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. , 2005, Physiological genomics.
[33] Hyun-seung Kim,et al. Cardiovascular disease in the elderly , 2005 .
[34] S. Akira,et al. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. , 2004, Cardiovascular research.
[35] L. Silengo,et al. PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects , 2004, Cell.
[36] J. Johnston. Are SOCS suppressors, regulators, and degraders? , 2004, Journal of leukocyte biology.
[37] E. Olson,et al. Hypertrophy of the heart: a new therapeutic target? , 2004, Circulation.
[38] D. Hilton,et al. Inhibitors of Cytokine Signal Transduction* , 2004, Journal of Biological Chemistry.
[39] D. Berrigan,et al. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. , 2003, Annual review of medicine.
[40] S. S. Zhang,et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] P. Kang,et al. Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. Ravussin,et al. Calorie restriction and aging: review of the literature and implications for studies in humans. , 2003, The American journal of clinical nutrition.
[43] M. Mattson,et al. Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. , 2003, The Journal of nutrition.
[44] H. Hsieh,et al. Shear Flow Attenuates Serum-induced STAT3 Activation in Endothelial Cells* , 2003, Journal of Biological Chemistry.
[45] A. Angelini,et al. α‐Actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study , 2003, The Journal of pathology.
[46] A. Lichtenberg,et al. Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated Cardiomyopathy , 2003, Circulation.
[47] D. Kass,et al. Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.
[48] Edward G Lakatta,et al. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging , 2003, Circulation.
[49] Daniel Levy,et al. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. , 2003, Circulation.
[50] Daniel Levy,et al. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. , 2003, Circulation.
[51] D. Aronson. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes , 2003, Journal of hypertension.
[52] G. Booz,et al. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. , 2002, Journal of molecular and cellular cardiology.
[53] Taber MacCallum,et al. Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[54] M. Matsuda,et al. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[55] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[56] J. Ross,et al. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. , 2001, The Journal of clinical investigation.
[57] N. Maulik,et al. Role of STAT3 in ischemic preconditioning. , 2001, Journal of molecular and cellular cardiology.
[58] J. Stern,et al. Calorie restriction in obesity: prevention of kidney disease in rodents. , 2001, Journal of NutriLife.
[59] T. Aoyagi,et al. Hemodynamic Overload–Induced Activation of Myocardial Mitogen-Activated Protein Kinases In Vivo: Augmented Responses in Young Spontaneously Hypertensive Rats and Diminished Responses in Aged Fischer 344 Rats , 2001, Hypertension.
[60] R. Kitsis,et al. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.
[61] K. Weber. Fibrosis and hypertensive heart disease , 2000, Current opinion in cardiology.
[62] J. Gardin,et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.
[63] M. Okabe,et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[64] M. Weckström,et al. Catecholamines in pericardial fluid of normotensive, spontaneously hypertensive and reserpine-treated rats. , 1999, Acta physiologica Scandinavica.
[65] Xinmin Cao,et al. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK) , 1998, Oncogene.
[66] P. Abete,et al. Alterations in β-adrenoceptor mechanisms in the aging heart. Relationship with heart failure , 1997, Aging.
[67] R. Weindruch,et al. Caloric Intake and Aging , 1997 .
[68] A. Patzak,et al. Does low frequency power of arterial blood pressure reflect sympathetic tone? , 1995, Journal of the autonomic nervous system.
[69] T. Lee,et al. Transforming growth factor-beta response elements of the skeletal alpha-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. , 1994, The Journal of biological chemistry.
[70] E. Lakatta,et al. Expression of the sarcomeric actin isogenes in the rat heart with development and senescence. , 1992, Circulation research.
[71] T. Parker,et al. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. , 1990, The Journal of clinical investigation.
[72] M. Buckingham,et al. α‐Skeletal Muscle Actin mRNA's Accumulate in Hypertrophied Adult Rat Hearts , 1986, Circulation research.
[73] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[74] D. Zipes,et al. Cardiovascular Disease in the Elderly , 2023, Contemporary Cardiology.
[75] G. Poli,et al. Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation. , 2010, Free radical biology & medicine.
[76] 犬塚 康孝. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice , 2009 .
[77] C. Padovani,et al. Misclassification probability as obese or lean in hypercaloric and normocaloric diet. , 2008, Biological research.
[78] W. Elliott. Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients , 2008 .
[79] J. Nyman,et al. Calorie Restriction Prevents Age-Related Trabecular Bone Loss via SIRT , 2008 .
[80] S. McKiernan,et al. Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats. , 2006, American journal of physiology. Heart and circulatory physiology.
[81] S. Clément,et al. Correlation of alpha-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats. , 2006, Experimental physiology.
[82] David A. Kass,et al. Age-related Changes in Venticular–Arterial Coupling: Pathophysiologic Implications , 2004, Heart Failure Reviews.
[83] D. Roith. Insulin-like Growth Factors , 2024 .
[84] T. Ishimitsu,et al. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. , 2000, Journal of cardiovascular pharmacology.
[85] Shokei Kim,et al. Cardiac mitogen-activated protein kinase activities are chronically increased in stroke-prone hypertensive rats. , 1998, Hypertension.
[86] R. Weindruch,et al. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. , 1997, The New England journal of medicine.
[87] G. L. Peterson. Determination of total protein. , 1983, Methods in enzymology.
[88] G. L. Peterson. [12] Determination of total protein , 1983 .